Table of Contents Table of Contents
Previous Page  4 / 68 Next Page
Show Menu
Previous Page 4 / 68 Next Page
Page Background



Lab Times




Picture of the issue / Bratislava Declaration of Young Researchers presented / Publishing costs at

eLIFE / Recently awarded / Microbiologist accused of fraud / Support for Turkish scientists

demanded / Reluctant data sharing at Queen Mary University of London / Israeli scientists construct

origami nanorobots and unfold a whole new world of drug delivery

_ ____________________ 6-12


Observations of The Owl:

Why Not Self-Plagiarise?

___________________________________ 13

Research letter from... The Czech Republic:

Virtual Flowers

_____________________________ 14

Over the Line?

Keeping the Parasite Out

_ _________________________________________ 15


Cover Story

Another troubling doping case is questioning WADA’s credibility again

_____________________ 16

The Language of Science

Scientific publications have evolved their very own linguistic style, difficult to understand.

_ _____ 20


Scientists are feverishly working on the second generation of biofuels. Will they be successful?

_ _ 26

Journal Club


What’s the molecular basis of the fatal genetic disease Wolfram syndrome?

____ 30


How did cetaceans adapt their metabolism, when returning to water?

__________ 32


Can an orderly mathematical model explain disorderly phyllotaxis?

_ ____ 34

Publication Statistics

Urology research in Europe

____________________________________________________ 36



British funding backs Austrian Zika vaccine / Irish start-up electrifies Novartis fund / French

biotech scenery shows growing activity

_ __________________________________________ 39

Going public – but not in Europe

Swiss biotech companies AC Immune and CRISPR Therapeutics announce Nasdaq IPOs

_ ______ 40

Company Portrait

In 1996, a successful autologous chondrocyte implantation was “hour zero” for Slovenian

regenerative medicine. One year later, Educell was established in Ljubljana, to produce

biomaterials for tissue engineering and cell therapies

_________________________________ 42


Product Survey:

Microplate readers

_ ___________________________________________ 46

New products

_____________________________________________________________ 57


Bench philosophy: Mechanotyping of cells

_ _______________________________________ 54

Tips and tricks of the trade: Reproducing spare parts by moulding

________________________ 56

Book Reviews

Publishing without tears:

Scientific Paper Writing

by Bodil Holst and Jorge Cham

_ ___________ 59


Researcher Profiles

Georg Nagel and the beginnings of optogenetics

_ ___________________________________ 60


_ __________________________________________________________________ 62


________________________________________________________________ 63


Paul the Postdoc

_ __________________________________________________________ 06


__________________________________________________________________ 65

Laboratory Tales

_ __________________________________________________________ 67

Producing bioethanol from maize and sugar-

cane turned out to be a bad idea. Are biofuels

from genetically-modified trees, algae and

bacteria a better solution? (p. 26)

Wolfram syndrome causes diabetes, deafness

and depression. Allen Kaasik and his team

found that a mutated protein in the ER leads

to an energy crisis in mitochondria (p. 30)

Educell from Slovenia, an “early runner” in

the regenerative medicine business, produc-

es biomaterials for multiple tissue engineer-

ing and cell therapy purposes (p. 42)

Mechanical phenotyping is an alternative

means for detecting rare cells and predicting

phenotypes. Steven Buckingham reports on

new mechanotyping techniques (p. 54)

Photo: Fotolia/angelo19

Photo: Pixabay/unsplash

Photo: Julien Husson

Photo: S. Zurga